A61M 1/1617
Using measurements made during a temporary variation of a characteristic of the
Official title: {using measurements made during a temporary variation of a characteristic of the fresh dialysis fluid}
A61M1/1617 (Using measurements made during a temporary variation of a characteristic of the) appears on 61 US grants and 53 published applications in this corpus.
Search patents in A61M- Granted patents
- 61
- Published applications
- 53
- Assignees
- 18
- Inventors
- 85
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 2 | 0 |
| 2005 | 3 | 6 |
| 2006 | 1 | 4 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 2 | 0 |
| 2010 | 6 | 3 |
| 2011 | 1 | 3 |
| 2012 | 1 | 2 |
| 2013 | 1 | 4 |
| 2014 | 4 | 3 |
| 2015 | 2 | 3 |
| 2016 | 4 | 0 |
| 2017 | 2 | 3 |
| 2018 | 1 | 2 |
| 2019 | 1 | 5 |
| 2020 | 4 | 1 |
| 2021 | 3 | 2 |
| 2022 | 3 | 4 |
| 2023 | 0 | 1 |
| 2024 | 2 | 1 |
| 2025 | 3 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extracorporeal blood treatment device with function-monitoring system28 Apr 2026US 12,611,493 B2Pulsion Medical Systems AG
- Apparatus for extracorporeal treatment of blood and method for determining a parameter indicative of the progress of an extracorporeal blood treatment21 Oct 2025US 12,447,248 B2Gambro Lundia AB
- System, computer system and computer program for determining a cardiovascular parameter14 Oct 2025US 12,440,613 B2Pulsion Medical Systems AG
- Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate24 Jun 2025US 12,337,093 B2Fresenius Medical Care Deutschland GmbH
- Sensor and apparatus for determining at least one parameter of blood circulating in an extracorporeal blood circuit9 Jul 2024US 12,029,555 B2Gambro Lundia AB
- Measurement of recirculation by means of two interim switches having kinetically different diffusion states13 Mar 2025US 2025/0082833 A1
- Apparatus, sensor and process for determining at least one parameter of blood circulating in an extracorporeal blood circuit24 Oct 2024US 2024/0350040 A1Gambro Lundia AB
- Dialysis apparatus having an apparatus for determining at least two hemodialysis parameters8 Jun 2023US 2023/0173154 A1Fresenius Medical Care Deutschland GmbH
- Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate8 Sep 2022US 2022/0280707 A1Fresenius Medical Care Deutschland GmbH
- Extracorporeal blood treatment device with function-monitoring system11 Aug 2022US 2022/0249751 A1Pulsion Medical Systems AG
Most cited
By later US patents
- Process for determining the operability of the structural components in the dialysis section of a dialyzer of a hemodialysis apparatus and apparatus for executing this process268US 5,580,460 AFresenius AG · 1996
- Method for the in-vivo determination of hemodialysis parameters202US 5,100,554 AFresenius AG · 1992
- Method and system for optimizing dialysis clearance202US 5,507,723 ABaxter International Inc. · 1996
- Dialysis system and method therefor180US 5,024,756 AGambro AB · 1991
- Haemodialysis device124US 7,563,240 B2Fresenius Medical Care Deutschland GmbH · 2009